359 related articles for article (PubMed ID: 23583454)
1. Substituted methcathinones differ in transporter and receptor interactions.
Eshleman AJ; Wolfrum KM; Hatfield MG; Johnson RA; Murphy KV; Janowsky A
Biochem Pharmacol; 2013 Jun; 85(12):1803-15. PubMed ID: 23583454
[TBL] [Abstract][Full Text] [Related]
2. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
Pifl C; Reither H; Hornykiewicz O
Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters.
Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Swanson TL; Nilsen A; Janowsky A
Psychopharmacology (Berl); 2019 Mar; 236(3):939-952. PubMed ID: 30397775
[TBL] [Abstract][Full Text] [Related]
4. α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter: A pharmacological characterization of interactions between pyrrolidinopropiophenones and high and low affinity monoamine transporters.
Maier J; Rauter L; Rudin D; Niello M; Holy M; Schmid D; Wilson J; Blough BE; Gannon BM; Murnane KS; Sitte HH
Neuropharmacology; 2021 Jun; 190():108570. PubMed ID: 33864800
[TBL] [Abstract][Full Text] [Related]
5. Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release.
Eshleman AJ; Wolfrum KM; Reed JF; Kim SO; Swanson T; Johnson RA; Janowsky A
J Pharmacol Exp Ther; 2017 Jan; 360(1):33-47. PubMed ID: 27799294
[TBL] [Abstract][Full Text] [Related]
6. 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α
Halberstadt AL; Brandt SD; Walther D; Baumann MH
Psychopharmacology (Berl); 2019 Mar; 236(3):989-999. PubMed ID: 30904940
[TBL] [Abstract][Full Text] [Related]
7. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.
Cameron KN; Kolanos R; Solis E; Glennon RA; De Felice LJ
Br J Pharmacol; 2013 Apr; 168(7):1750-7. PubMed ID: 23170765
[TBL] [Abstract][Full Text] [Related]
8. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
Anneken JH; Angoa-Pérez M; Kuhn DM
J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
[TBL] [Abstract][Full Text] [Related]
9. Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.
Cameron K; Kolanos R; Vekariya R; De Felice L; Glennon RA
Psychopharmacology (Berl); 2013 Jun; 227(3):493-9. PubMed ID: 23371489
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
[TBL] [Abstract][Full Text] [Related]
11. Hypothesizing that designer drugs containing cathinones ("bath salts") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption.
Blum K; Foster Olive M; Wang KK; Febo M; Borsten J; Giordano J; Hauser M; Gold MS
Med Hypotheses; 2013 Sep; 81(3):450-5. PubMed ID: 23845561
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs.
Cozzi NV; Brandt SD; Daley PF; Partilla JS; Rothman RB; Tulzer A; Sitte HH; Baumann MH
Eur J Pharmacol; 2013 Jan; 699(1-3):180-7. PubMed ID: 23178523
[TBL] [Abstract][Full Text] [Related]
13. Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and Norepinephrine.
Janowsky A; Tosh DK; Eshleman AJ; Jacobson KA
J Pharmacol Exp Ther; 2016 Apr; 357(1):24-35. PubMed ID: 26813929
[TBL] [Abstract][Full Text] [Related]
14. Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters.
Severinsen K; Kraft JF; Koldsø H; Vinberg KA; Rothman RB; Partilla JS; Wiborg O; Blough B; Schiøtt B; Sinning S
ACS Chem Neurosci; 2012 Sep; 3(9):693-705. PubMed ID: 23019496
[TBL] [Abstract][Full Text] [Related]
15. Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone.
López-Arnau R; Martínez-Clemente J; Pubill D; Escubedo E; Camarasa J
Br J Pharmacol; 2012 Sep; 167(2):407-20. PubMed ID: 22509960
[TBL] [Abstract][Full Text] [Related]
16. Non-conserved residues dictate dopamine transporter selectivity for the potent synthetic cathinone and psychostimulant MDPV.
Steele TWE; Spires Z; Jones CB; Glennon RA; Dukat M; Eltit JM
Neuropharmacology; 2021 Dec; 200():108820. PubMed ID: 34619165
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological Actions of Synthetic Cathinones on Monoamine Transporters.
Solis E
Curr Top Behav Neurosci; 2017; 32():73-92. PubMed ID: 27677783
[TBL] [Abstract][Full Text] [Related]
18. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.
Baumann MH; Ayestas MA; Partilla JS; Sink JR; Shulgin AT; Daley PF; Brandt SD; Rothman RB; Ruoho AE; Cozzi NV
Neuropsychopharmacology; 2012 Apr; 37(5):1192-203. PubMed ID: 22169943
[TBL] [Abstract][Full Text] [Related]
19. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones.
Rickli A; Hoener MC; Liechti ME
Eur Neuropsychopharmacol; 2015 Mar; 25(3):365-76. PubMed ID: 25624004
[TBL] [Abstract][Full Text] [Related]
20. Monoamine transporter and receptor interaction profiles of a new series of designer cathinones.
Simmler LD; Rickli A; Hoener MC; Liechti ME
Neuropharmacology; 2014 Apr; 79():152-60. PubMed ID: 24275046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
